SARS CoV-2 seroprevalence in a US school district during COVID-19

Sean S M Bullis; Benjamin Grebber; Sally Cook; Nancy R Graham; Marya Carmolli; Dorothy Dickson; Sean A Diehl; Beth D Kirkpatrick; Benjamin Lee

doi:10.1136/bmjpo-2021-001259

Article info

PDF

PDF +
Supplementary
Material

Original research letter

SARS CoV-2 seroprevalence in a US school district during COVID-19

Authors

Sean S M Bullis Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont, USA PubMed articles Google scholar articles
Benjamin Grebber University of Vermont College of Medicine, Burlington, VT, USA PubMed articles Google scholar articles
Sally Cook Vermont Department of Health, Burlington, Vermont, USA PubMed articles Google scholar articles
Nancy R Graham Department of Microbiology and Molecular Genetics, University of Vermont College of Medicine, Burlington, Vermont, USA PubMed articles Google scholar articles
Marya Carmolli Department of Microbiology and Molecular Genetics, University of Vermont College of Medicine, Burlington, Vermont, USA PubMed articles Google scholar articles
Dorothy Dickson Department of Microbiology and Molecular Genetics, University of Vermont College of Medicine, Burlington, Vermont, USA PubMed articles Google scholar articles
Sean A Diehl Department of Microbiology and Molecular Genetics, University of Vermont College of Medicine, Burlington, Vermont, USA PubMed articles Google scholar articles
Beth D Kirkpatrick Department of Medicine, University of Vermont College of Medicine, Burlington, Vermont, USADepartment of Microbiology and Molecular Genetics, University of Vermont College of Medicine, Burlington, Vermont, USA PubMed articles Google scholar articles
Benjamin Lee Department of Pediatrics, University of Vermont College of Medicine, Burlington, VT, USA PubMed articles Google scholar articles

Correspondence to Dr Benjamin Lee; blee7{at}uvm.edu

View Full Text

Citation

Bullis SSM, Grebber B, Cook S, et al

SARS CoV-2 seroprevalence in a US school district during COVID-19

BMJ Paediatrics Open 2021;5:e001259. doi: 10.1136/bmjpo-2021-001259

Publication history

Received August 11, 2021
Accepted September 18, 2021
First published October 27, 2021.

Online issue publication

January 18, 2023

Previous versions

Review history

Supplementary Data

This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Data supplement 1

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Supplementary Data

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password